Nuo Therapeutics, Inc.
AURX
$1.23
$0.043.36%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 18.55% | -1.00% | -8.11% | 2.01% | 8.24% |
| Total Depreciation and Amortization | 39.44% | 63.21% | 62.93% | 50.58% | 21.23% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 537.73% | 699.62% | 662.46% | -24.55% | -58.96% |
| Change in Net Operating Assets | -156.19% | -73.14% | 3,485.56% | 858.52% | 551.72% |
| Cash from Operations | -201.19% | 0.98% | 61.24% | 61.33% | 73.76% |
| Capital Expenditure | 22.35% | 88.13% | -77.29% | -49.42% | -6,275.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 22.35% | 88.13% | -77.29% | -49.42% | -6,275.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -3.67% | -48.04% | -48.04% | -61.92% | -66.44% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 174.61% | 9.38% | -19.33% | -61.92% | -66.44% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 184.81% | 167.00% | 141.11% | -465.23% | -312.62% |